CA199 Human Native Protein
€0.00
In stock
SKU
BNP1033
Description:
Purified human Cancer Antigen CA199 protein
Background:
CA19-9 (carbohydrate antigen 19-9, also called cancer antigen 19-9 or sialylated Lewis (a) antigen) is a tumor marker that is used primarily in the management of pancreatic cancer. Guidelines from the American Society of Clinical Oncology discourage the use of CA19-9 as a screening test for cancer, particularly pancreatic cancer. The reason is that the test may be falsely normal (false negative) in many cases, or abnormally elevated in people who have no cancer at all (false positive). The main use of CA19-9 is therefore to see whether a pancreatic tumor is secreting it; if that is the case, then the levels should fall when the tumor is treated, and they may rise again if the disease recurs. CA19-9 can be elevated in many types of gastrointestinal cancer, such as colorectal cancer, esophageal cancer and hepatocellular carcinoma. Apart from cancer, elevated levels may also occur in pancreatitis, cirrhosis, and diseases of the bile ducts. It can be elevated in people with obstruction of the bile ducts.
Synonyms:
Cancer Antigen CA19-9, CA 19-9, carbohydrate antigen 19-9, cancer antigen 19-9, sialylated Lewis antigen, Lewis antigen, Sialyl-Lewis A, Lewis a, sialylated Lewis a antigen, CA199, CA19-9, CA 199, CA 19-9
Application: SDS-PAGE
Purity: >90% by SDS-PAGE
Formulation: Liquid
Storage buffer: Each vial contains 10 mM PBS, pH 7.4±0.2.
Storage and Expiration:
Ship at 4℃.Upon receipt, aliquot andstore at -20℃for long term. Avoid repeated freeze and thaw cycles.
Purified human Cancer Antigen CA199 protein
Background:
CA19-9 (carbohydrate antigen 19-9, also called cancer antigen 19-9 or sialylated Lewis (a) antigen) is a tumor marker that is used primarily in the management of pancreatic cancer. Guidelines from the American Society of Clinical Oncology discourage the use of CA19-9 as a screening test for cancer, particularly pancreatic cancer. The reason is that the test may be falsely normal (false negative) in many cases, or abnormally elevated in people who have no cancer at all (false positive). The main use of CA19-9 is therefore to see whether a pancreatic tumor is secreting it; if that is the case, then the levels should fall when the tumor is treated, and they may rise again if the disease recurs. CA19-9 can be elevated in many types of gastrointestinal cancer, such as colorectal cancer, esophageal cancer and hepatocellular carcinoma. Apart from cancer, elevated levels may also occur in pancreatitis, cirrhosis, and diseases of the bile ducts. It can be elevated in people with obstruction of the bile ducts.
Synonyms:
Cancer Antigen CA19-9, CA 19-9, carbohydrate antigen 19-9, cancer antigen 19-9, sialylated Lewis antigen, Lewis antigen, Sialyl-Lewis A, Lewis a, sialylated Lewis a antigen, CA199, CA19-9, CA 199, CA 19-9
Application: SDS-PAGE
Purity: >90% by SDS-PAGE
Formulation: Liquid
Storage buffer: Each vial contains 10 mM PBS, pH 7.4±0.2.
Storage and Expiration:
Ship at 4℃.Upon receipt, aliquot andstore at -20℃for long term. Avoid repeated freeze and thaw cycles.
| Is Featured? | No |
|---|
Write Your Own Review